Rein Therapeutics, Inc. Common Stock (NASDAQ: RNTX) last traded at $0.818, up 3.07% on the session. The quote above updates while this page is open; the figures below are drawn from Rein Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Rein Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RNTX. Its market capitalisation is $70.57 million.
Valuation measures for Rein Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $70.57M |
|---|---|
| Enterprise value | $72.79M |
| Price / book | 1.28 |
| Beta | 1.53 |
Trailing-twelve-month figures tagged in Rein Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$49.76M |
| Return on equity | -90.14% |
| Cash | $8.54M |
Range and volume for RNTX over the past 52 weeks.
| 52-week high | $2.18 |
|---|---|
| 52-week low | $0.694 |
| Volume | 576.0K |
| Average volume | 512.0K |
| Previous close | $0.794 |
Dividend history for Rein Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.